1Gali N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension : the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J, 2009, 30 : 2493-2537. 被引量：1
2Sims MW, Margolis D J, Localio AR, et al. Impact of pulmonary artery pressure on exercise function in severe COPD. Chest, 2009, 136 : 412-419. 被引量：1
3Cuttica M J, Kalhan R, Shlobin OA, et al. Categorization and impact of pulmonary hypertension in patients with advanced COPD. Respir Med, 2010, 104: 1877-1882. 被引量：1
4Andersen KH, Iversen M, Kjaergaard J, et al. Prevalence, predictors, and survival in pulmonary hypertension related to end- stage chronic obstructive pulmonary disease. J Heart Lung Transplant, 2012, 31: 373-380. 被引量：1
5Weitzenblum E, Chaouat A. Severe pulmonary hypertension in COPD: is it a distinct disease?. Chest, 2005, 127: 1480-1482. 被引量：1
6Thabut G, Dauriat G, Stem JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest, 2005, 127 : 1531-1536. 被引量：1
7Zakynthinos E, Daniil Z, Papanikolaou J, et al. Pulmonary hypertension in COPD: pathophysiology and therapeutic targets. Curr Drag Targets, 2011, 12: 501-513. 被引量：1
8Orr R, Smith LJ, Cuttica MJ. Pulmonary hypertension in advanced chronic obstructive pulmonary disease. Curt Opin Pulm Med, 2012, 18: 138-143. 被引量：1
9Sims MW, Margolis D J, Localio AR, et al. Impact of pulmonary artery pressure on exercise function in severe COPD. Chest, 2009, 136 :412-419. 被引量：1
10Stone AC, Machan JT, Maser J, et al. Echocardiographic evidence of pulmonary hypertension is associated with increased 1- year mortality in patients admitted with chronic obstructive pulmonary disease. Lung, 2011, 189: 207-212. 被引量：1
